Bronchiolitis: Adopting a unifying definition and a comprehensive etiological classification

Expert Review of Respiratory Medicine

Volumn 7, Issue 3, 2013, Pages 289-306

  Papiris, Spyros A ^a   Malagari, Katerina ^b   Manali, Effrosyni D ^a   Kolilekas, Likurgos ^a   Triantafillidou, Christina ^c   Baou, Katerina ^c   Rontogianni, Dimitra ^d   Bouros, Demosthenes ^e   Kagouridis, Konstantinos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Evgenidion Hospital   (Greece)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d EVANGELISMOS HOSPITAL   (Greece)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

constrictive bronchiolitis obliterans; small airways diseases; small airways inflammation and fibrosis; small airways obstruction

Indexed keywords

ABACAVIR; ACEBUTOLOL; AMIODARONE; AMPHOTERICIN B; AZATHIOPRINE; BLEOMYCIN; BUCILLAMINE; BUSULFAN; CARBAMAZEPINE; CEPHALOSPORIN; CHLORAMBUCIL; CYTARABINE; CYTARABINE 5' STEARYLPHOSPHATE; DAPTOMYCIN; DOXORUBICIN; EVEROLIMUS; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MINOCYCLINE; NITROFURANTOIN; OXALIPLATIN; PHENYTOIN; RAPAMYCIN; RITUXIMAB; SULINDAC; TACROLIMUS; TICLOPIDINE; UNINDEXED DRUG;

ACUTE DISEASE; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ASTHMA; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHURG STRAUSS SYNDROME; CONNECTIVE TISSUE DISEASE; CRYPTOGENIC CONSTRICTIVE BRONCHIOLITIS; DIFFUSE ASPIRATION BRONCHIOLITIS; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; DIFFUSE PANBRONCHIOLITIS; DISEASE CLASSIFICATION; ENTERITIS; FUME; GAS; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; LANGERHANS CELL HISTIOCYTOSIS; LOEFFLER PNEUMONIA; LUNG GRANULOMATOSIS; NEOPLASM; NEUROENDOCRINE HYPERPLASIA; NONHUMAN; REVIEW; SARCOIDOSIS; SMOKING;

EID: 84878735683     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.13.21     Document Type: Review

References (139)

1. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am. J. Respir. Crit. Care Med. 168(11), 1277-1292 (2003).
2. Poletti V, Costabel U. Bronchiolar disorders: classification and diagnostic approach. Semin. Respir. Crit. Care Med. 24(5), 457-464 (2003).
3. Devakonda A, Raoof S, Sung A, Travis WD, Naidich D. Bronchiolar disorders: a clinical-radiological diagnostic algorithm. Chest 137(4), 938-951 (2010).
4. Poletti V, Casoni G, Zompatori M, Carloni A, Cancelieri A, Chilosi M. Bronchiolitis. Eur. Respir. Mon. S4, 84-103 (2011).
5. Kradin R. The pathology of pulmonary infection. In: Fishman's Pulmonary Diseases and Disorders (4th Edition). Fishman AP (Ed.). McGraw-Hill, NY, USA, 2031-2050 (2008).
6. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch. Int. Med. 30, 689-760 (1922).
7. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 135(3), 805-826 (2009).
8. Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am. Rev. Respir. Dis. 111(4), 497-537 (1975).
9. Girard M, Lacasse Y, Cormier Y. Hypersensitivity pneumonitis. Allergy 64(3), 322-334 (2009).
10. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 60(7), 841-857 (2005).
11. Katzenstein AL. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am. J. Clin. Pathol. 114(5), 767-772 (2000).
12. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 278(25), 1355-1360 (1968).
13. Patel RR, Ryu JH, Vassallo R. Cigarette smoking and diffuse lung disease. Drugs 68(11), 1511-1527 (2008).
14. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N. Engl. J. Med. 342(26), 1969-1978 (2000).
15. Zwemer FL Jr, Pratt DS, May JJ. Silo filler's disease in New York State. Am. Rev. Respir. Dis. 146(3), 650-653 (1992).
16. Franquet T, Giménez A, Rosón N, Torrubia S, Sabaté JM, Pérez C. Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics 20(3), 673-685 (2000).
17. Churg A, Wright JL. Bronchiolitis caused by occupational and ambient atmospheric particles. Semin. Respir. Crit. Care Med. 24(5), 577-584 (2003).
18. Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis. BMJ 339, b3206 (2009).
19. Kraft M, Mortenson RL, Colby TV, Newman L, Waldron JA Jr, King TE Jr. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am. Rev. Respir. Dis. 148(4 Pt 1), 1093-1101 (1993).
20. Yamanaka A, Saeki S, Tamura S, Saito K. The problems of chronic obstructive pulmonary disease: especially diffuse panbronchiolitis. Nakai-Inter. Med. 23, 442-451 (1969).
21. Aguayo SM, Miller YE, Waldron JA Jr, et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N. Engl. J. Med. 327(18), 1285-1288 (1992).
22. Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr. Pulmonol. 40(2), 157-165 (2005).
23. Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 140(2), 502-508 (2011).
24. Lynch DA. Lung disease related to collagen vascular disease. J. Thorac. Imaging 24(4), 299-309 (2009).
25. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 131(2), 524-532 (2007).
26. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 312(3), 152-158 (1985).
27. Miller WS. The Lung. Charles C Thomas, IL, USA, 39-42 (1947).
28. Webb WR. Thin-section CT of the secondary pulmonary lobule: anatomy and the image-the 2004 Fleischner lecture. Radiology 239(2), 322-338 (2006).
29. Ochs M, Weibel ER. Functional design of the human lung for gas exchange. In: Fishman's Pulmonary Diseases and Disorders (4th Edition). McGraw-Hill, NY, USA, 23-70 (2008).
30. Rice A, Nicholson AG. The pathologist's approach to small airways disease. Histopathology 54(1), 117-133 (2009).
31. Müller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. Radiology 196(1), 3-12 (1995).
32. Remy-Jardin M, Artaud D, Fribourg M. Multiplanar and three-dimensional reconstruction techniques in CT: impact on chest diseases. Eur. Radiol. 8, 335-351 (1998).
33. Teel GS, Engeler CE, Tashijian JH, duCret RP. Imaging of small airways disease. Radiographics 16(1), 27-41 (1996).
34. Hansell DM. Computed tomography of diffuse lung disease: functional correlates. Eur. Radiol. 11(9), 1666-1680 (2001).
35. Aquino SL, Gamsu G, Webb WR, Kee ST. Tree-in-bud pattern: frequency and significance on thin section CT. J. Comput. Assist. Tomogr. 20(4), 594-599 (1996).
36. Collins J, Blankenbaker D, Stern EJ. CT patterns of bronchiolar disease: what is 'tree-in-bud'? AJR Am. J. Roentgenol. 171(2), 365-370 (1998).
37. Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. AJR Am. J. Roentgenol. 185(2), 354-363 (2005).
38. Gruden JF, Webb WR, Warnock M. Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation. AJR Am. J. Roentgenol. 162(3), 569-574 (1994).
39. Gruden JF, Webb WR, Naidich DP, McGuinness G. Multinodular disease: anatomic localization at thin-section CT-multireader evaluation of a simple algorithm. Radiology 210(3), 711-720 (1999).
40. Logan PM, Primack SL, Miller RR, Müller NL. Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. Radiology 193(2), 383-388 (1994).
41. Webb RW, Higgins CB. Thoracic Imaging: Pulmonary and Cardiovascular Radiology. Lippincott Williams & Wilkins, PA, USA, 357 (2004)
42. Lynch DA. Imaging of small airways diseases. Clin. Chest Med. 14(4), 623-634 (1993).
43. Basheda SG, Mehta AC, De Boer G, Orlowski JP. Endobronchial and parenchymal juvenile laryngotracheobronchial papillomatosis. Effect of photodynamic therapy. Chest 100(5), 1458-1461 (1991).
44. Janoski MM, Raymond GS, Puttagunta L, Man GC, Barrie Jr. Psyllium aspiration causing bronchiolitis: radiographic, high-resolution CT, and pathologic findings. AJR Am. J. Roentgenol. 174(3), 799-801 (2000).
45. Okada F, Ando Y, Yoshitake S, et al. Clinical/pathologic correlations in 553 patients with primary centrilobular findings on high-resolution CT scan of the thorax. Chest 132(6), 1939-1948 (2007).
46. Selman-Lama M, Pérez-Padilla R. Airflow obstruction and airway lesions in hypersensitivity pneumonitis. Clin. Chest Med. 14(4), 699-714 (1993).
47. Hogg JC. Lung structure and function in COPD. Int. J. Tuberc. Lung Dis. 12(5), 467-479 (2008).
48. Hyde DM, Hamid Q, Irvin CG. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J. Allergy Clin. Immunol. 124(Suppl. 6), S72-S77 (2009).
49. Schindler M. Do bronchodilators have an effect on bronchiolitis? Crit. Care 6(2), 111-112 (2002).
50. Burgel PR, Bourdin A, Chanez P, et al. Update on the roles of distal airways in COPD. Eur. Respir. Rev. 20(119), 7-22 (2011).
51. Andersen P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 53(4), 302-307 (1998).
52. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 368(9532), 312-322 (2006).
53. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20(1), 108-119 (2007).
54. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 118, 1774-1793 (2006).
55. Committee on Infectious Diseases. From the American Academy of Pediatrics: policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 124, 1694-1701 (2009).
56. Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr. Opin. Pediatr. 20, 272-278 (2008).
57. Quigley MJ, Fraser RS. Pulmonary pneumatocele: pathology and pathogenesis. AJR Am. J. Roentgenol. 150(6), 1275-1277 (1988).
58. Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am. J. Surg. Pathol. 14(7), 615-625 (1990).
59. Chow C, Templeton PA, White CS. Lung cysts associated with Pneumocystis carinii pneumonia: radiographic characteristics, natural history, and complications. AJR Am. J. Roentgenol. 161(3), 527-531 (1993).
60. Hunter RL, Jagannath C, Actor JK. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb.) 87(4), 267-278 (2007).
61. Hunter RL. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinb.) 91(6), 497-509 (2011).
62. Hunter RL. On the pathogenesis of post primary tuberculosis: the role of bronchial obstruction in the pathogenesis of cavities. Tuberculosis (Edinb.) 91(Suppl. 1), S6-S10 (2011).
63. Cole PJ. Bronchiectasis. In: Respiratory Medicine (2nd Edition). Brewis RAL, Corin B, Geddes DM, Gibson GJ (Eds). WB Saunders, London, UK, 1286-1316 (1995).
64. King P. Pathogenesis of bronchiectasis. Paediatr. Respir. Rev. 12(2), 104-110 (2011).
65. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 373(9678), 1891-1904 (2009).
66. Tiddens HA, Donaldson SH, Rosenfeld M, Paré PD. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatr. Pulmonol. 45(2), 107-117 (2010).
67. Warren EL, McFadden Jr ER. Sudden death in asthma. In: Asthma. Barnes PJ, Grunstein MM, Leff AR, et al. (Eds). Lippincott-Raven, PA, USA, 1945-1954 (1997).
68. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am. Rev. Respir. Dis. 142(1), 108-111 (1990).
69. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148(3), 713-719 (1993).
70. Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I. Acute severe asthma: new approaches to assessment and treatment. Drugs 69(17), 2363-2391 (2009).
71. Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J. Allergy Clin. Immunol. 100(1), 44-51 (1997).
72. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am. J. Respir. Crit. Care Med. 154(5), 1505-1510 (1996).
73. Kraft M. The distal airways: are they important in asthma? Eur. Respir. J. 14(6), 1403-1417 (1999).
74. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc. Am. Thorac. Soc. 7(3), 237-244 (2010).
75. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin. Dev. Immunol. 2011, 843763 (2011).
76. Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front. Biosci. 8, e190-e196 (2003).
77. Myers JL. Bronchocentric granulomatosis. Disease or diagnosis? Chest 96(1), 3-4 (1989).
78. Lacasse Y, Selman M, Costabel U, et al.; HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 168(8), 952-958 (2003).
79. Coleman A, Colby TV. Histologic diagnosis of extrinsic allergic alveolitis. Am. J. Surg. Pathol. 12(7), 514-518 (1988).
80. Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod. Pathol. 14(12), 1284-1293 (2001).
81. Kim YK, Lee KS, Chung MP, et al. Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur. Radiol. 17(12), 3157-3165 (2007).
82. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364(9435), 709-721 (2004).
83. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N. Engl. J. Med. 365(17), 1567-1575 (2011).
84. Hogg JC, McDonough JE, Sanchez PG, et al. Micro-computed tomography measurements of peripheral lung pathology in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6(6), 546-549 (2009).
85. Beasley MB. Smoking-related small airway disease-a review and update. Adv. Anat. Pathol. 17(4), 270-276 (2010).
86. Rao RN, Goodman LR, Tomashefski JF Jr. Smoking-related interstitial lung disease. Ann. Diagn. Pathol. 12(6), 445-457 (2008).
87. Wells AU, Hirani N, on behalf of the British Thoracic Society Interstitial Lung Disease Guideline Group, a subgroup of the British Thoracic Society Standards of Care Committee, in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63, 1-58 (2008).
88. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 41(3), 316-325 (2010).
89. Katzenstein AL. Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod. Pathol. 25(Suppl. 1), S68-S78 (2012).
90. Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 127(1), 178-184 (2005).
91. Sigala I, Kalomenidis I, Malagari K, et al. Dry cough and dyspnoea rapidly increasing to respiratory failure in a male smoker. Eur. Respir. J. 25(6), 1122-1125 (2005).
92. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N. Engl. J. Med. 346(7), 484-490 (2002).
93. Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin. Chest Med. 33(1), 165-178 (2012).
94. King MS, Eisenberg R, Newman JH, et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N. Engl. J. Med. 365(3), 222-230 (2011).
95. Mann JM, Sha KK, Kline G, Breuer FU, Miller A. World Trade Center dyspnea: bronchiolitis obliterans with functional improvement: a case report. Am. J. Ind. Med. 48(3), 225-229 (2005).
96. Nena E, Steiropoulos P, Constantinidis TC, Bouros D. Beyond pneumonoconiosis: recently described occupational interstitial lung diseases. Pneumon. 3, 297-300 (2010).
97. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N. Engl. J. Med. 344(9), 665-671 (2001).
98. Matsuse T, Oka T, Kida K, Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 110(5), 1289-1293 (1996).
99. Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 184(12), 1390-1394 (2011).
100. Raghu G. Idiopathic pulmonary fibrosis: increased survival with 'gastroesophageal reflux therapy': fact or fallacy? Am. J. Respir. Crit. Care Med. 184(12), 1330-1332 (2011).
101. Churg A, Brauer M, Vedal S, Stevens B. Ambient mineral particles in the small airways of the normal human lung. J. Environ. Med. 1, 39-46 (1999).
102. Churg A, Wright JL, Wiggs B, Paré PD, Lazar N. Small airways disease and mineral dust exposure. Prevalence, structure, and function. Am. Rev. Respir. Dis. 131(1), 139-143 (1985).
103. Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf. 33(7), 539-558 (2010).
104. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest 139(1), 174-182 (2011).
105. Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J. R. Coll. Surg. Edinb. 41(1), 7-13 (1996).
106. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur. Respir. J. 20(3), 750-762 (2002).
107. Papiris SA, Kalomenidis I, Malagari K, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir. Med. 101(1), 84-92 (2007).
108. Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA, Nichols PW. Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients. Pathology 18(3), 283-288 (1986).
109. Colby TV, Carrington CB, Mark GJ. Pulmonary involvement of malignant histiocytosis: a clinicopathologic spectrum. Am. J. Surg. Pathol. 5(1), 61-73 (1981).
110. Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N. Engl. J. Med. 340(18), 1406-1410 (1999).
111. Colby TV. Bronchiolitis. Pathologic considerations. Am. J. Clin. Pathol. 109(1), 101-109 (1998).
112. Homma H. Diffuse panbronchiolitis. Jpn. J. Thorac. Dis. 13, 383-395 (1975).
113. Homma H. Definition of diffuse panbronchiolitis. Jpn. J. Intern. Med. 65, 645-659 (1976).
114. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am. J. Respir. Crit. Care Med. 154(2 Pt 1), 497-503 (1996).
115. Zompatori M, Poletti V. Diffuse panbronchiolitis. An Italian experience. Radiol. Med. 94(6), 680-682 (1997).
116. Martinez JA, Guimarães SM, Ferreira RG, Pereira CA. Diffuse panbronchiolitis in Latin America. Am. J. Med. Sci. 319(3), 183-185 (2000).
117. Scheuermann DW. Neuroendocrine cells. In: The Lung: Scientific Foundations (2nd Edition). Crystal RG, West JB, Weibel ER, Barnes PJ (Eds). Lippincott-Raven Publishers, PA, USA, 603-613 (1997).
118. Degan S, Lopez GY, Kevill K, Sunday ME. Gastrin-releasing peptide, immune responses, and lung disease. Ann. NY Acad. Sci. 1144, 136-147 (2008).
119. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62(3), 248-252 (2007).
120. Nassar AA, Jaroszewski DE, Helmers RA, Colby TV, Patel BM, Mookadam F. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am. J. Respir. Crit. Care Med. 184(1), 8-16 (2011).
121. Young LR, Brody AS, Inge TH, et al. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest 139(5), 1060-1071 (2011).
122. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J. Heart Lung Transplant. 21(3), 297-310 (2002).
123. Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. J. Cardiothorac. Surg. 6, 92 (2011).
124. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 16(Suppl. 1), S106-S114 (2010).
125. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: mechanisms and therapy. Proc. Am. Thorac. Soc. 6(1), 108-121 (2009).
126. Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann. Rheum. Dis. 58(1), 61-64 (1999).
127. Papiris SA, Moutsopoulos HM. The lung in Sjögren's syndrome. In: Pulmonary Involvement in Systemic Autoimmune Diseases. Wells A, Denton C (Eds). Elsevier, London, UK, 161-180 (2004).
128. Papiris SA, Tsonis I, Moutsopoulos HM. Pulmonary complications in Sjögren's syndrome. Sem. Respir. Crit. Care Med. 28, 459-472 (2007).
129. Papiris SA, Saetta M, Turato G, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am. J. Respir. Crit. Care Med. 156(2 Pt 1), 637-641 (1997).
130. Borie R, Schneider S, Debray M-P, Adle-Biassette H, Danel C, Bergeron A, et al. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Res. Med. 105, 130-136 (2011).
131. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am. J. Respir. Crit. Care Med. 157(5 Pt 1), 1658-1665 (1998).
132. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19), 2275-2285 (2006).
133. Devouassoux G, Cottin V, Lioté H, et al.; Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur. Respir. J. 33(5), 1053-1061 (2009).
134. Fortoul TI, Cano-Valle F, Oliva E, Barrios R. Follicular bronchiolitis in association with connective tissue diseases. Lung 163(5), 305-314 (1985).
135. Camus P, Colby TV. The lung in inflammatory bowel disease. Eur. Respir. J. 15(1), 5-10 (2000).
136. Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 65(Suppl. 1), i1-i58 (2010).
137. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch. Intern. Med. 161(2), 158-164 (2001).
138. American Thoracic Society/European Respiratory Society. Classification of the idiopathic interstitial pneumonias: international multidisciplinary consensus. Am. J. Respir. Crit. Care Med. 165, 277-304 (2002).
139. Foucher P, Camus P, GEPPI. The druginduced lung diseases. www.pneumotox.com (Accessed 12 December 2012)